Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rittner

Showing results (141-150 of 610) with videos related to

Pageof 61
Sort By:
Die Pharmazie|March 10, 2001
Synthesis of some new neostigmine methyl sulphates and related compoundsR Rittner, J E Barbarini, N F Höehr
Tissue Antigens|February 1, 1984
Coeliac disease and C4A*QO: an association secondary to HLA-DR3C Rittner, M DeMarchi, E Mollenhauer, et al.
Clinical Allergy|May 1, 1978
Pigeon breeders' lung lacking detectable antibodiesJ Sennekamp, D Niese, I Stroehmann, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 1, 1996
Genetic polymorphism of the fourth component of human complement: population study and proposal for a revised nomenclature based on genomic PCR typing of Rodgers and Chido determinantsP M Schneider, B Stradmann-Bellinghausen, C Rittner
Social Science & Medicine (1982)|January 1, 1982
The social context of active distress in patients with early myocardial infarctionJ Siegrist, K Dittmann, K Rittner, et al.
Annals of the New York Academy of Sciences|October 28, 1992
Antisense RNA-mediated inhibition of the replication of the human immunodeficiency virus type 1. Discussion of critical parametersG Sczakiel, M Pawlita, K Rittner, et al.
Das Offentliche Gesundheitswesen|February 1, 1983
[Subjective perception of myocardial infarct and its causes]J Mrazek, V Rittner, P Seer, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|March 8, 2002
The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studiesK Witzel-Schlömp, C Rittner, P M Schneider
European Journal of Medicinal Chemistry|November 30, 2007
Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSARJoão E Antunes, Matheus P Freitas, Roberto Rittner
Cancer Gene Therapy|February 24, 2007
Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studiesK Rittner, V Schreiber, P Erbs, et al.
Pageof 61

Showing results (141-150 of 610) with videos related to

Sort By:
Pageof 61
Die Pharmazie|March 10, 2001
Synthesis of some new neostigmine methyl sulphates and related compoundsR Rittner, J E Barbarini, N F Höehr
Tissue Antigens|February 1, 1984
Coeliac disease and C4A*QO: an association secondary to HLA-DR3C Rittner, M DeMarchi, E Mollenhauer, et al.
Clinical Allergy|May 1, 1978
Pigeon breeders' lung lacking detectable antibodiesJ Sennekamp, D Niese, I Stroehmann, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 1, 1996
Genetic polymorphism of the fourth component of human complement: population study and proposal for a revised nomenclature based on genomic PCR typing of Rodgers and Chido determinantsP M Schneider, B Stradmann-Bellinghausen, C Rittner
Social Science & Medicine (1982)|January 1, 1982
The social context of active distress in patients with early myocardial infarctionJ Siegrist, K Dittmann, K Rittner, et al.
Annals of the New York Academy of Sciences|October 28, 1992
Antisense RNA-mediated inhibition of the replication of the human immunodeficiency virus type 1. Discussion of critical parametersG Sczakiel, M Pawlita, K Rittner, et al.
Das Offentliche Gesundheitswesen|February 1, 1983
[Subjective perception of myocardial infarct and its causes]J Mrazek, V Rittner, P Seer, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|March 8, 2002
The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studiesK Witzel-Schlömp, C Rittner, P M Schneider
European Journal of Medicinal Chemistry|November 30, 2007
Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSARJoão E Antunes, Matheus P Freitas, Roberto Rittner
Cancer Gene Therapy|February 24, 2007
Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studiesK Rittner, V Schreiber, P Erbs, et al.
Pageof 61